PTPA and neoplasm: PP2A activity is widely considered to be tumor suppressive (26), with B56 (α/β/γ/δ/ε) containing holoenzymes emerging as key negative regulators of tumorigenesis (28), and inactivation of PP2A is essential for malignant transformation (28, 29).